Clinical Trial Update: Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) [Phase 4]

View source ↗

Summary

RABBIT is a Phase 4 trial evaluating bedside BNP in the treatment of heart failure, sponsored by Abbott RDx Cardiometabolic. The study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Heart Failure | Phase 4 | Status: TERMINATED